Treatment with ranolazine increases the number of antitumour lymphocytes that infiltrate the tumour and favour the action of immunotherapy (IMAGE)
Institute for Research in Biomedicine (IRB Barcelona)
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.